✦ LIBER ✦

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

✍ Scribed by A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; B. Barin; A. McMichael; J. Weber; K. Legg; A. Babiker; P. Hayes; F. Gotch; C. Smith; L. Dally; L. Dorrell; I. Cebere; R. Kay; N. Winstone; S. Moore; N. Goonetilleke; P. Fast

Book ID: 116960938
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 498 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.09.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Lessons from IAVI-006, a

Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Phase I clinical trial safety of DNA- an

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

✍ Inese Cebere; Lucy Dorrell; Helen McShane; Alison Simmons; Sheena McCormack; Cla 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 289 KB